Genuity Science, a clinical and genomics data, analytics and insights organisation, will deliver a keynote address at BioTechX Genomics Live! on Tuesday, 8th November at 9.20am CET. The conference, formerly known as BioData EU / Genomics Live!, will be held in Basel, Switzerland November 8th – 11th, 2022.
This 20-minute presentation will focus on:
Title: Accelerating Precision Medicine in Cardiometabolic and CNS Diseases: Drug Target discovery from large cohorts with WGS, longitudinal clinical data, and disease tissue snRNA sequencing
Presenter: Jeffrey Gulcher, M.D., Ph.D., Co-Founder and Chief Scientific Officer, Genuity Science
Session: Genomics Live! Main Stage
Time/Date: Tuesday, 8th November, 9.20am CET
Dr. Gulcher, a longstanding scientific leader in the field of genomics, co-founded NextCODE, the precurser to Genuity Science, in 2013 following on from ground-breaking massive-scale population genetics work conducted in Iceland at deCODE genetics, a company that he co-founded with Dr. Kári Stefánsson in 1996.
Gulcher previously served as a neurologist at Beth Israel Hospital and Harvard Medical School and received his PhD. and M.D. from the University of Chicago. He has authored more than 200 peer-reviewed publications on the genetics of common/complex diseases.
BioTechX successfully brings together an amalgamation of genomics, translational medicine, data scientists, IT, bioinformaticians, cheminformaticians, clinicians, healthcare and pharma companies. The event, established in 2018, showcases innovation and demonstrated in genomics and big data.
To learn more about the conference and how to register, visit https://www.terrapinn.com/conference/biotechx/